RIPK1 anticorps (C-Term)
Aperçu rapide pour RIPK1 anticorps (C-Term) (ABIN2751275)
Antigène
Voir toutes RIPK1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 620-670, C-Term
-
Purification
- Affinity Purified
-
Immunogène
- Synthetic peptide taken within amino acid region 620-670 on human Receptor-interacting Serine/Threonine-protein kinase 1 protein.
-
Isotype
- IgG
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.55-0.75 μg/μL
-
-
- RIPK1 (Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1))
-
Autre désignation
- RIPK1
-
UniProt
- Q13546
-
Pathways
- Signalisation NF-kappaB, Apoptose, Caspase Cascade in Apoptosis, Signalisation TLR, Activation of Innate immune Response, Inositol Metabolic Process, Positive Regulation of Endopeptidase Activity, Hepatitis C, Protein targeting to Nucleus, Toll-Like Receptors Cascades, Negative Regulation of intrinsic apoptotic Signaling, SARS-CoV-2 Protein Interactome, Ubiquitin Proteasome Pathway
Antigène
-